RV41 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Fennec Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 5.9 EUR Market Closed

Market Cap: €94.3m

F	Fennec Pharmaceuticals Inc SWB:RV41	US
A	Airtel Africa PLC XBER:9AA	UK
	Global Education Communities Corp TSX:GEC	CA
	RWE AG MIL:1RWE	DE
F	Fortuna Silver Mines Inc LSE:0QYM	CA
S	SSR Mining Inc TSX:SSRM	CA
	PCI- PAL PLC LSE:PCIP	UK
S	Swiss Re AG XBER:SR9	CH
C	Commerzbank AG DUS:CBK	DE
P	PICC Property and Casualty Co Ltd SWB:PJC	CN

Profitability Summary

Fennec Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

92%

Strong 3Y Average Gross Margin

93%

Declining Gross Margin

94% > 92%

Negative Operating Margin

-14%

Negative 3Y Average Operating Margin

-56%

Operating Margin is Increasing

-755% > -14%

Negative Net Margin

-22%

Negative 3Y Average Net Margin

-68%

Net Margin is Increasing

-810% > -22%

Negative Free Cash Flow Margin

-28%

Negative 3Y Average Free Cash Flow Margin

-43%

Free Cash Flow Margin is Increasing

-645% > -28%

Negative ROE

-66%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-1 327%

ROIC is Increasing

-32 427% > -29%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.